MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study

Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring meth...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lancet neurology 2011-12, Vol.10 (12), p.1065-1073
Hauptverfasser: Verhey, Leonard H, BSc, Branson, Helen M, MBBS, Shroff, Manohar M, MD, Callen, David JA, MD, Sled, John G, PhD, Narayanan, Sridar, PhD, Sadovnick, A Dessa, Prof, Bar-Or, Amit, MD, Arnold, Douglas L, Prof, Marrie, Ruth Ann, MD, Banwell, Brenda, Dr
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1073
container_issue 12
container_start_page 1065
container_title Lancet neurology
container_volume 10
creator Verhey, Leonard H, BSc
Branson, Helen M, MBBS
Shroff, Manohar M, MD
Callen, David JA, MD
Sled, John G, PhD
Narayanan, Sridar, PhD
Sadovnick, A Dessa, Prof
Bar-Or, Amit, MD
Arnold, Douglas L, Prof
Marrie, Ruth Ann, MD
Banwell, Brenda, Dr
description Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation.
doi_str_mv 10.1016/S1474-4422(11)70250-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_912917046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1474442211702502</els_id><sourcerecordid>912917046</sourcerecordid><originalsourceid>FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0Eou3CTwBZXCiHgMeJEy8HEFrxUamAROFsOfaEdUniYCdF-xv40zibZQ-99OTR-J1nPl5CngB7CQzKV1dQVEVWFJyfA7yoGBcs4_fI6SFdivvHmPMTchbjNWMcCgkPyQnnrKzKXJySv5-_XdBBB93hiCHSxgc6BLTOjM731De0m9rRDS3SaFoMPrpIrdM_-33kemq2rrUBe_rHjVuqzTQi3Xy5oha7Hbau1zPoNdUJ6-OAiXuDdMnqlhq_9WGkcZzs7hF50Og24uPDuyI_Prz_vvmUXX79eLF5d5kZkbMxQ1NIDnVjEJiRArXVlumqYrIq13WVflghpa4bobURQgMXNod1UzPk61zLfEWeL9w00e8J46g6Fw22re7RT1Gtga-hYkV5t5JVIEuesCvy7Jby2k8hbTiLhJRQFnNjsYhMOkUM2KghuE6HnQKmZlfV3lU1W6YA1N5VxVPd0wN8qju0x6r_NibB20WA6Ww3DoOKxmFvko8hXVxZ7-5s8eYWwSTvnNHtL9xhPC4DKnLFFsjMANgTeP4PQc3Iag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>905881648</pqid></control><display><type>article</type><title>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Verhey, Leonard H, BSc ; Branson, Helen M, MBBS ; Shroff, Manohar M, MD ; Callen, David JA, MD ; Sled, John G, PhD ; Narayanan, Sridar, PhD ; Sadovnick, A Dessa, Prof ; Bar-Or, Amit, MD ; Arnold, Douglas L, Prof ; Marrie, Ruth Ann, MD ; Banwell, Brenda, Dr</creator><creatorcontrib>Verhey, Leonard H, BSc ; Branson, Helen M, MBBS ; Shroff, Manohar M, MD ; Callen, David JA, MD ; Sled, John G, PhD ; Narayanan, Sridar, PhD ; Sadovnick, A Dessa, Prof ; Bar-Or, Amit, MD ; Arnold, Douglas L, Prof ; Marrie, Ruth Ann, MD ; Banwell, Brenda, Dr ; for the Canadian Pediatric Demyelinating Disease Network ; Canadian Pediatric Demyelinating Disease Network</creatorcontrib><description>Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(11)70250-2</identifier><identifier>PMID: 22067635</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute Disease ; Adolescence ; Adolescent ; Brain - pathology ; Brain research ; Brain stem ; Central nervous system ; Child ; Children ; Clinical trials ; Cohort analysis ; Demyelinating Diseases - diagnosis ; Demyelinating Diseases - pathology ; Demyelination ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Multiple sclerosis ; Multiple Sclerosis - diagnosis ; Multiple Sclerosis - pathology ; Nerve Fibers, Myelinated - pathology ; Neurology ; Pediatrics ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Substantia alba</subject><ispartof>Lancet neurology, 2011-12, Vol.10 (12), p.1065-1073</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</citedby><cites>FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1474442211702502$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22067635$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Verhey, Leonard H, BSc</creatorcontrib><creatorcontrib>Branson, Helen M, MBBS</creatorcontrib><creatorcontrib>Shroff, Manohar M, MD</creatorcontrib><creatorcontrib>Callen, David JA, MD</creatorcontrib><creatorcontrib>Sled, John G, PhD</creatorcontrib><creatorcontrib>Narayanan, Sridar, PhD</creatorcontrib><creatorcontrib>Sadovnick, A Dessa, Prof</creatorcontrib><creatorcontrib>Bar-Or, Amit, MD</creatorcontrib><creatorcontrib>Arnold, Douglas L, Prof</creatorcontrib><creatorcontrib>Marrie, Ruth Ann, MD</creatorcontrib><creatorcontrib>Banwell, Brenda, Dr</creatorcontrib><creatorcontrib>for the Canadian Pediatric Demyelinating Disease Network</creatorcontrib><creatorcontrib>Canadian Pediatric Demyelinating Disease Network</creatorcontrib><title>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation.</description><subject>Acute Disease</subject><subject>Adolescence</subject><subject>Adolescent</subject><subject>Brain - pathology</subject><subject>Brain research</subject><subject>Brain stem</subject><subject>Central nervous system</subject><subject>Child</subject><subject>Children</subject><subject>Clinical trials</subject><subject>Cohort analysis</subject><subject>Demyelinating Diseases - diagnosis</subject><subject>Demyelinating Diseases - pathology</subject><subject>Demyelination</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - diagnosis</subject><subject>Multiple Sclerosis - pathology</subject><subject>Nerve Fibers, Myelinated - pathology</subject><subject>Neurology</subject><subject>Pediatrics</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Substantia alba</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU1v1DAQhi0Eou3CTwBZXCiHgMeJEy8HEFrxUamAROFsOfaEdUniYCdF-xv40zibZQ-99OTR-J1nPl5CngB7CQzKV1dQVEVWFJyfA7yoGBcs4_fI6SFdivvHmPMTchbjNWMcCgkPyQnnrKzKXJySv5-_XdBBB93hiCHSxgc6BLTOjM731De0m9rRDS3SaFoMPrpIrdM_-33kemq2rrUBe_rHjVuqzTQi3Xy5oha7Hbau1zPoNdUJ6-OAiXuDdMnqlhq_9WGkcZzs7hF50Og24uPDuyI_Prz_vvmUXX79eLF5d5kZkbMxQ1NIDnVjEJiRArXVlumqYrIq13WVflghpa4bobURQgMXNod1UzPk61zLfEWeL9w00e8J46g6Fw22re7RT1Gtga-hYkV5t5JVIEuesCvy7Jby2k8hbTiLhJRQFnNjsYhMOkUM2KghuE6HnQKmZlfV3lU1W6YA1N5VxVPd0wN8qju0x6r_NibB20WA6Ww3DoOKxmFvko8hXVxZ7-5s8eYWwSTvnNHtL9xhPC4DKnLFFsjMANgTeP4PQc3Iag</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>Verhey, Leonard H, BSc</creator><creator>Branson, Helen M, MBBS</creator><creator>Shroff, Manohar M, MD</creator><creator>Callen, David JA, MD</creator><creator>Sled, John G, PhD</creator><creator>Narayanan, Sridar, PhD</creator><creator>Sadovnick, A Dessa, Prof</creator><creator>Bar-Or, Amit, MD</creator><creator>Arnold, Douglas L, Prof</creator><creator>Marrie, Ruth Ann, MD</creator><creator>Banwell, Brenda, Dr</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20111201</creationdate><title>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</title><author>Verhey, Leonard H, BSc ; Branson, Helen M, MBBS ; Shroff, Manohar M, MD ; Callen, David JA, MD ; Sled, John G, PhD ; Narayanan, Sridar, PhD ; Sadovnick, A Dessa, Prof ; Bar-Or, Amit, MD ; Arnold, Douglas L, Prof ; Marrie, Ruth Ann, MD ; Banwell, Brenda, Dr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c530t-ec4821bfce10c85eadad0a7708769b71bf0488abf5aac55a125d319fb0e293a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Disease</topic><topic>Adolescence</topic><topic>Adolescent</topic><topic>Brain - pathology</topic><topic>Brain research</topic><topic>Brain stem</topic><topic>Central nervous system</topic><topic>Child</topic><topic>Children</topic><topic>Clinical trials</topic><topic>Cohort analysis</topic><topic>Demyelinating Diseases - diagnosis</topic><topic>Demyelinating Diseases - pathology</topic><topic>Demyelination</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - diagnosis</topic><topic>Multiple Sclerosis - pathology</topic><topic>Nerve Fibers, Myelinated - pathology</topic><topic>Neurology</topic><topic>Pediatrics</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Substantia alba</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Verhey, Leonard H, BSc</creatorcontrib><creatorcontrib>Branson, Helen M, MBBS</creatorcontrib><creatorcontrib>Shroff, Manohar M, MD</creatorcontrib><creatorcontrib>Callen, David JA, MD</creatorcontrib><creatorcontrib>Sled, John G, PhD</creatorcontrib><creatorcontrib>Narayanan, Sridar, PhD</creatorcontrib><creatorcontrib>Sadovnick, A Dessa, Prof</creatorcontrib><creatorcontrib>Bar-Or, Amit, MD</creatorcontrib><creatorcontrib>Arnold, Douglas L, Prof</creatorcontrib><creatorcontrib>Marrie, Ruth Ann, MD</creatorcontrib><creatorcontrib>Banwell, Brenda, Dr</creatorcontrib><creatorcontrib>for the Canadian Pediatric Demyelinating Disease Network</creatorcontrib><creatorcontrib>Canadian Pediatric Demyelinating Disease Network</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Verhey, Leonard H, BSc</au><au>Branson, Helen M, MBBS</au><au>Shroff, Manohar M, MD</au><au>Callen, David JA, MD</au><au>Sled, John G, PhD</au><au>Narayanan, Sridar, PhD</au><au>Sadovnick, A Dessa, Prof</au><au>Bar-Or, Amit, MD</au><au>Arnold, Douglas L, Prof</au><au>Marrie, Ruth Ann, MD</au><au>Banwell, Brenda, Dr</au><aucorp>for the Canadian Pediatric Demyelinating Disease Network</aucorp><aucorp>Canadian Pediatric Demyelinating Disease Network</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>10</volume><issue>12</issue><spage>1065</spage><epage>1073</epage><pages>1065-1073</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><coden>LANCAO</coden><abstract>Summary Background Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination. Methods Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS. Findings Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144–337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46–78·0) or one or more periventricular lesions (3·34, 1·27–8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69–70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models. Interpretation Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. Funding Canadian Multiple Sclerosis Scientific Research Foundation.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>22067635</pmid><doi>10.1016/S1474-4422(11)70250-2</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1474-4422
ispartof Lancet neurology, 2011-12, Vol.10 (12), p.1065-1073
issn 1474-4422
1474-4465
language eng
recordid cdi_proquest_miscellaneous_912917046
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acute Disease
Adolescence
Adolescent
Brain - pathology
Brain research
Brain stem
Central nervous system
Child
Children
Clinical trials
Cohort analysis
Demyelinating Diseases - diagnosis
Demyelinating Diseases - pathology
Demyelination
Female
Humans
Magnetic Resonance Imaging
Male
Multiple sclerosis
Multiple Sclerosis - diagnosis
Multiple Sclerosis - pathology
Nerve Fibers, Myelinated - pathology
Neurology
Pediatrics
Predictive Value of Tests
Prognosis
Prospective Studies
Substantia alba
title MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T12%3A49%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MRI%20parameters%20for%20prediction%20of%20multiple%20sclerosis%20diagnosis%20in%20children%20with%20acute%20CNS%20demyelination:%20a%20prospective%20national%20cohort%20study&rft.jtitle=Lancet%20neurology&rft.au=Verhey,%20Leonard%20H,%20BSc&rft.aucorp=for%20the%20Canadian%20Pediatric%20Demyelinating%20Disease%20Network&rft.date=2011-12-01&rft.volume=10&rft.issue=12&rft.spage=1065&rft.epage=1073&rft.pages=1065-1073&rft.issn=1474-4422&rft.eissn=1474-4465&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1474-4422(11)70250-2&rft_dat=%3Cproquest_cross%3E912917046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=905881648&rft_id=info:pmid/22067635&rft_els_id=S1474442211702502&rfr_iscdi=true